Insider · CIK 0001938192
Paul Andrew Moore
officer
Files at ZYME (Zymeworks Inc.). First filing Jan 5, 2026, latest Jan 12, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $721k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZYME: Zymeworks Inc.
ZYMEOct 9, 2026 · close 25.79
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | Zymeworks Inc. | $217k 9,560 shares | -16% | +145% from low-16% from high | |
| 43Moderate | Zymeworks Inc. | $505k 20,110 shares | -50% | +170% from low-8% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | ZYME Zymeworks Inc. | MOption exercise Common Stock | +17,666 | $0.00 | $0 | 58,057 | Jan 12, 2026 |
| Jan 12, 2026 | ZYME Zymeworks Inc. | SOpen-market sale Common Stock | -9,560 | $22.67 | $217k | 48,497 | Jan 12, 2026 |
| Jan 12, 2026 | ZYME Zymeworks Inc. | MOption exercise Restricted Stock Unitderivative | -17,666 | $0.00 | $0 | 35,334 | Jan 12, 2026 |
| Jan 12, 2026 | ZYME Zymeworks Inc. | AGrant or award Stock Option (Right to Buy)derivative | +70,000 | $0.00 | $0 | 70,000 | Jan 12, 2026 |
| Jan 12, 2026 | ZYME Zymeworks Inc. | AGrant or award Restricted Stock Unitderivative | +47,000 | $0.00 | $0 | 47,000 | Jan 12, 2026 |
| Jan 12, 2026 | ZYME Zymeworks Inc. | AGrant or award Performance Stock Unitderivative | +66,000 | $0.00 | $0 | 66,000 | Jan 12, 2026 |
| Jan 5, 2026 | ZYME Zymeworks Inc. | MOption exercise Common Stock | +17,168 | $0.00 | $0 | 40,501 | Jan 5, 2026 |
| Jan 5, 2026 | ZYME Zymeworks Inc. | SOpen-market sale Common Stock | -9,289 | $25.10 | $233k | 31,212 | Jan 5, 2026 |
| Jan 5, 2026 | ZYME Zymeworks Inc. | MOption exercise Common Stock | +20,000 | $0.00 | $0 | 51,212 | Jan 5, 2026 |
| Jan 5, 2026 | ZYME Zymeworks Inc. | SOpen-market sale Common Stock | -10,821 | $25.10 | $272k | 40,391 | Jan 5, 2026 |
| Jan 5, 2026 | ZYME Zymeworks Inc. | MOption exercise Restricted Stock Unitderivative | -17,168 | $0.00 | $0 | 0 | Jan 5, 2026 |
| Jan 5, 2026 | ZYME Zymeworks Inc. | MOption exercise Restricted Stock Unitderivative | -20,000 | $0.00 | $0 | 20,000 | Jan 5, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.